Rectal Neoplasms 
Welcome,         Profile    Billing    Logout  

3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rectal Neoplasms
HyRec, NCT01716949: Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer

Recruiting
1/2
59
Europe
Radiotherapy, Hyperthermia, 5-Fluorouracil, all brands of 5-Fluorouracil are allowed, Capecitabine, all brands of Capecitabine are allowed, Oxaliplatin, all brands of oxaliplatin are allowed
University of Erlangen-Nürnberg Medical School
Rectal Cancer
06/22
06/23
NCT02164136: Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients

Recruiting
N/A
172
RoW
L-PANP-TME, O-PANP-TME
Third Affiliated Hospital, Sun Yat-Sen University
Rectum Neoplasms
06/19
06/23
NCT02165800: Multicenter Study on Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients

Recruiting
N/A
667
RoW
L-PANP-TME, O-PANP-TME
Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Sixth Affiliated Hospital, Sun Yat-sen University, Nanfang Hospital of Southern Medical University, Southern Medical University, China
Rectum Neoplasms
12/19
12/23

Download Options